Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper

Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing

(2013) J. Bousquet et al.   ALLERGY

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care

(2013) P. Demoly et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: The ESPIA questionnaire

(2013) José Luis Justicia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Chronic Care Model and Diabetes Management in US Primary Care Settings: A Systematic Review

(2013) Michael Stellefson et al.   Preventing Chronic Disease

An introduction to patient decision aids

(2013)   BMJ-British Medical Journal

Assessment of disease control in allergic rhinitis

(2013) Pascal Demoly et al.   Clinical and Translational Allergy

RhinAsthma Patient Perspective: a short daily asthma and rhinitis QoL assessment

(2012) F. Braido et al.   ALLERGY

Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials

(2012) Moises A. Calderon et al.   Current Opinion in Allergy and Clinical Immunology

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

(2012) Robert L. Jacobs et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: A double-blind, placebo-controlled study

(2012) Ulrich Wahn et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

(2012) Warner Carr et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

(2012) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

(2012) Deepen Patel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes

(2012) Guy W. Scadding et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis

(2012) Esther Röder et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Prospective validation of the "rhino conjunctivitis allergy-control-SCORE(C)" (RC-ACS(C))

(2012) Dietrich Häfner et al.   Clinical and Translational Allergy

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time

(2012) Joao A Fonseca et al.   Clinical and Translational Allergy

Prospective validation of ‘Allergy-Control-SCORETM’: a novel symptom-medication score for clinical trials

(2011) D. Häfner et al.   ALLERGY

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

(2011) O. Pfaar et al.   ALLERGY

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen

(2011) Lawrence M. DuBuske et al.   ALLERGY AND ASTHMA PROCEEDINGS

The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials

(2011) J.-M. Grouin et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Validation of a self-questionnaire for assessing the control of allergic rhinitis

(2011) P. Demoly et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?

(2011) O. Pfaar et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children

(2011) Piotr Kuna et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA2LEN taskforce position paper

(2010) F. Braido et al.   ALLERGY

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials

(2010) S. R. Durham et al.   ALLERGY

A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis

(2010) N. Franzke et al.   ALLERGY

Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis

(2010) Herbert Riechelmann et al.   American Journal of Rhinology & Allergy

Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions

(2010) J. M. Hohlfeld et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study

(2010) Oliver Pfaar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

(2010) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life

(2009) L. Frølund et al.   ALLERGY

‘Well days’ after sublingual immunotherapy with a high-dose 6-grass pollen preparation

(2009) M. Worm   ALLERGY

Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies

(2009) G. W. Canonica et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Unmet needs in severe chronic upper airway disease (SCUAD)

(2009) Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

(2009) Albrecht Bufe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Response to sublingual immunotherapy with grass pollen extract: Monotherapy versus combination in a multiallergen extract

(2009) Sheila M. Amar et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

(2009) Friedrich Horak et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis

(2009) Philippe-Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy

(2008) A. Didier et al.   ALLERGY

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

(2008) James N. Francis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY